What's New
Winston-Salem Man Celebrates Freedom From Dialysis After Kidney Transplant at Duke
Winston-Salem attorney Erik Harvey spent eight years on dialysis before he was approved for a kidney transplant. On the day he became eligible, his long-time friend and colleague, Elizabeth Lawson, signed up to donate a kidney to him. Thanks to her eagerness and Duke Health’s quick donor testing process, Harvey had a new kidney in just two months. Now, one year later, he’s enjoying life free from dialysis and celebrating his 50th birthday.
New Drug Renews Hope in People with Pancreatic Cancer
A pill called daraxonrasib has been shown to increase survival rates in previously treated people with metastatic pancreatic cancer, according to a study published in the New England Journal of Medicine. While the drug has yet to be approved by the FDA, people with pancreatic cancer who have had chemotherapy can access daraxonrasib at Duke Health through an expanded access program. “We haven't had advances in metastatic pancreatic cancer like this for more than 15 years.” said Duke Health medical oncologist Niharika B. Mettu, MD, PhD.
Multifidus Stimulation Helps Strengthen Muscles to Reduce Low Back Pain
A new neurostimulation device is helping people find relief from chronic lower back pain by rebuilding weak multifidus muscles, which help stabilize the lower spine. Called multifidus stimulation, the treatment has been shown to reduce pain in three to six months after the device is surgically implanted. Here, Duke spine surgeon Peter Passias, MD, explains how multifidus stimulation works and whether you could be eligible.
Learn how multifidus stimulation works.
Duke Health Blog
-
No Evidence of Disease Thanks to New Pancreatic Cancer Drug DaraxonrasibRead Article -
Family History Leads to Surveillance at Young Age and Finds Early Breast CancerRead Article -
Lifelong Baseball Fan Receives Heart Transplant and Finds Camaraderie at DukeRead Article -
Should I See a Doctor for Cyclosporiasis?Read Article